Heraud J.M.; Mortreux F.; Merien F.; Contamin H.; Mahieux R.; Pouliquen J.F.; Wattel E.; Gessain A.; de The H.; Bazarbachi A.; Hermine O.; Kazanji M.
(AMSTERDAMPO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS, 2006)
Human T-cell lymphotropic virus type 1 (HTLV-1)-associated adult T-cell leukemia-lymphoma (ATLL) has a poor prognosis owing to its intrinsic resistance to chemotherapy. Although zidovudine (AZT) and alpha interferon (IFN-α) ...